Loading...
SKYX is not a good buy right now for an impatient investor. Despite bullish longer-term moving averages and a supportive analyst view, near-term momentum is weak (MACD negative and worsening) with the stock trading below the key pivot (2.745). Without a clear catalyst, options-sentiment read, or Intellectia buy signal to justify an immediate entry, the risk/reward is not compelling at 2.525.
Trend & Momentum: The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating the broader trend is constructive. However, momentum is currently soft: MACD histogram is negative (-0.00629) and negatively expanding, which typically signals fading upside/near-term downside pressure. RSI(6) at 45.59 is neutral, not indicating an oversold bounce setup.
Levels to watch: Price (2.525) is below the pivot (2.745), which leans bearish/neutral short-term. Immediate support is S1 at 2.363 (then S2 at 2.127). Overhead resistance is R1 at 3.127 (then R2 at 3.363). A quick move lower toward 2.363 is plausible if weakness continues.
Pattern-based forward bias: Similar-pattern stats suggest modest positive drift (about +0.55% next day, +1.12% next week, +7.08% next month), but that is not strong enough to override the current negative MACD.
Intellectia Proprietary Trading Signals
Latest quarter: 2025/Q3. Revenue grew to 23,891,537 (+7.77% YoY), indicating continued top-line expansion. Profitability remains a problem: net income declined to -7,902,926 (down -8.33% YoY) and EPS fell to -0.07 (down -12.50% YoY). A positive offset is gross margin improvement to 31.68 (+2.66% YoY), which supports a longer-term thesis of operational leverage, but the current quarter still shows losses widening rather than narrowing.
Recent trend: positive. Roth Capital (Gerry Sweeney) maintained a Buy rating and increased the price target to $5 from $4.25 on 2026-01-22.
Wall Street pro view (pros/cons): Pros include stated progress toward a potential business inflection point, new placements, better e-commerce execution, and broader distribution—factors that could lift revenue quality and margins. Cons are that the company is still generating losses with declining YoY EPS/net income, and the stock’s near-term technical momentum is not currently confirming the bullish narrative.